Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-23

Clinical Trial Update: Bioactive Milk Peptides and Blood Pressure [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating bioactive milk peptides for lowering blood pressure in Hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bioactive Milk Peptides (bioactive milk peptides)

Snippet

Sponsor: Valio Ltd | Conditions: Stage 1 Hypertension | Phase 3 | Status: COMPLETED